{"nct_id":"NCT04186871","title":"Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis","status":"COMPLETED","status_verified_date":"2024-01","start_date":"2020-01-07","start_date_type":"ACTUAL","primary_completion_date":"2022-12-05","primary_completion_date_type":"ACTUAL","completion_date":"2022-12-05","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["BMY"]}